Parkinson’s Disease (PD) affects an estimated 4-6 million people and their families all over the world. While there is still no cure, participating in
clinical trials can help future generations better understand and develop treatments for this debilitating condition.
Researchers at 98 clinics around the world are conducting a research
study to test an investigational medication aimed at reducing the effects
of levadopa (L-dopa) therapy when treating symptoms associated
with moderate to severe Parkinson’s Disease. We are looking for people
with moderate-to-severe Parkinson’s Disease, and their caregivers,
to participate.
Learn more about this PD study
You or someone in your care may be eligible to participate in this study.
Click the button below to answer a few questions to find out if you or someone in your care are eligible to participate in this PD study.
